ABSTRACT. Objective: Despite substantial attention being paid to the health benefi ts of moderate alcohol intake as a lifestyle, the acute effects of alcohol on psychomotor and working memory function in older adults are poorly understood. Method: The effects of low to moderate doses of alcohol on neurobehavioral function were investigated in 39 older (55-70 years; 15 men) and 51 younger (25-35 years; 31 men) social drinkers. Subjects received one of three randomly assigned doses (placebo, .04 g/dl, or .065 g/dl target breath alcohol concentration). After beverage consumption, they completed the Trail Making Test Parts A and B and a working memory task requiring participants to determine whether probe stimuli were novel or had been presented in a preceding set of cue stimuli. Effi ciency of working memory task performance was derived from accuracy and reaction time measures. Results: Alcohol was associated with poorer Trail Making Test Part B performance for older subjects. Working memory task results suggested an Age × Dose interaction for performance effi ciency, with older but not younger adults demonstrating alcohol-related change. Directionality of change and whether effects on accuracy or reaction time drove the change depended on the novelty of probe stimuli. Conclusions: This study replicates previous research indicating increased susceptibility of older adults to moderate alcoholinduced psychomotor and set-shifting impairment and suggests such susceptibility extends to working memory performance. Further research using additional tasks and assessing other neuropsychological domains is needed. (J. Stud. Alcohol Drugs, 75, 870-879, 2014) 
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Most work on acute low to moderate dose effects has focused on endpoint outcomes (e.g., completion time or accuracy) that may not be optimally sensitive to subtle defi cits as opposed to more sensitive process-oriented constructs (Kaplan, 1988) . Our work and others' have used the construct of cognitive effi ciency, conceptualized as the ability to work quickly and accurately at the same time, to address this concern. For example, both chronic alcoholism and normal aging are associated with defi cits in cognitive effi ciency (Carriere et al., 2010; Fillmore, 2007; Nixon, 1999) . Literature reviewed by Fillmore (2007) suggests that moderate alcohol doses may also undermine cognitive effi ciency.
Another limitation of the larger literature is that studies of acute moderate alcohol effects have included primarily young adults (Dougherty et al., 2008; Reed et al., 2012) . However, many older adults report moderate alcohol consumption (Substance Abuse and Mental Health Services Administration, 2011). Aging-related changes in body composition (e.g., reductions in lean body mass) may infl uence alcohol distribution and pharmacokinetics (Davies and Bowen, 1999; Gilbertson et al., 2009) . Furthermore, aging is often associated with subclinical cognitive decrements, including declines in processing speed and defi cits in suppression of attention to irrelevant stimuli (Charness, 2000; Gazzaley et al., 2005) . Taken together, these changes constitute a mechanism by which age may modulate the neurobehavioral effects of moderate alcohol intake. Indeed, research in our laboratory using the Trail Making Test (TMT; Reitan and Wolfson, 1993) suggests that adults 50-75 years of age demonstrate defi cits in psychomotor and set-shifting performance at BACs at which adults ages 25-35 years do not (i.e., ~.05 g/dl; Gilbertson et al., 2009) . Recent work us-ing a covert attention task (Luck et al., 1994; Posner, 1980) found evidence for speed/accuracy tradeoffs in older, but not younger, adults at BACs ~.05 g/dl (Sklar et al., 2012) . In addition, older adults show disruption of neurophysiological indices of working memory function (i.e., P300 amplitude and latency) at this level, but younger adults do not (Lewis et al., 2013) . These fi ndings suggest that further work is needed to (a) clarify potential age-dependent thresholds for dose effects on performance and (b) specify whether behavioral indices may be affected by age and alcohol interactions.
The current study was designed to address these issues. Specifi cally, we included three target BAC levels: 0 (placebo), .04 g/dl, and .065 g/dl. We administered a visual working memory task involving top-down attentional control (Gazzaley et al., 2005) . The TMT was also included for comparison with previous work (Reitan and Wolfson, 1993) . Based on earlier studies (Gilbertson et al., 2009) , we anticipated (a) age-related defi cits on TMT Part A, a simple psychomotor task; (b) that the .04 g/dl dose level would result in faster TMT Part A completion times for younger adults but no signifi cant dose effects for older adults; and (c) that both older age and alcohol dose would contribute to slower completion of the TMT Part B. In addition, we predicted that older adults' sensitivity to alcohol's negative effects would extend to the working memory task. We posed as an empirical question whether detrimental effects of age and alcohol on working memory effi ciency would be attributable to changes in accuracy and/or reaction time (RT).
Method

Study design
The study used a 2 (age: younger, 25-35; older, 55-70) × 3 (alcohol dose: placebo; low [0.04 g/dl] ; and moderate [0.065 g/dl]) double-blind, placebo-controlled, factorial design. Because our focus was on age and alcohol interactions, the upper cutoff for older adults was selected to minimize potential confounds associated with age-related cognitive decline. The University of Florida Health Science Center Institutional Review Board approved all procedures.
Screening
Community outreach occurred through fl yers and radio/ print advertisements. Interested individuals called the laboratory and were informed of basic inclusionary criteria, including (a) being between ages 25 and 35 or 55 and 70 years, (b) being a nonsmoker, (c) being in good physical health, (d) having at least a high school diploma but not more than a master's degree, (e) having no signifi cant history of head injury or unconsciousness, (f) having previous experience consuming alcohol, and (g) having no history of problems with alcohol or other substances. If, after hearing the criteria, individuals remained interested, they were scheduled for a screening session in the laboratory. Written informed consent was obtained before any data collection.
Basic screening measures included demographic assessments, drug and alcohol use histories, and state anxiety index (Spielberger, 1983 (Beck et al., 1996; Yesavage et al., 1982 Yesavage et al., -1983 . Average daily consumption of absolute ethanol in ounces over the 6 months before screening (quantity-frequency index or QFI) was determined (Cahalan et al., 1969) . Men were included if they had a QFI of 1.2 (~2 drinks/day); women were included if they had a QFI of 0.6 (~1 drink/day). Individuals completing screening were paid $15.
Persons continuing to qualify following screening provided a self-report of their medical history. Probabilistic psychiatric diagnoses were assessed with the computerized Diagnostic Interview Schedule IV (American Psychiatric Association, 2000; Robins et al., 1995) . Exclusionary psychiatric criteria included (a) current or lifetime diagnosis of alcohol or other substance dependence, including nicotine; (b) lifetime diagnosis of any psychotic disorder; and (c) current diagnosis of major depressive disorder (or lifetime diagnosis if electroconvulsive therapy was used for treatment). In addition, a history of serious medical illness-including uncontrolled type 2 diabetes, uncontrolled hypertension, epilepsy, HIV/AIDS, past incidence of powerful electric shock, prolonged periods of unconsciousness, or skull fracturewas exclusionary. Women who were pregnant or breastfeeding were also disqualifi ed. Individuals who completed the interview process received $37.50.
Prescription medication use
To enhance ecological validity and feasibility of recruitment, use of common prescription and over-the-counter medications was allowed provided the drug(s) did not contraindicate alcohol use. As expected, more older than younger adults reported medication use (61% vs. 25%, respectively). Commonly reported medications included birth control (55% of younger women), nonopioid analgesics (18.4% of older adults), and cholesterol medications (15.8% of older adults). A minority of participants had been stabilized for at least 3 months on selective serotonin or serotonin-norepinephrine reuptake inhibitors (2.0% of younger adults and 7.9% of older adults), antihypertensives (13.2% of older adults), or hormone replacement (8.3% of older women).
Laboratory phase
Laboratory sessions typically began at 9:00 A.M. (range: 8:00-10:30 A.M. because of travel, etc.). Subjects were asked to (a) fast for 4 hours before their scheduled session, (b) take normal morning medications, and (c) avoid over-the-counter allergy or sinus medications on the morning of testing. Subjects were questioned regarding their compliance with these guidelines before study sessions. In addition, subjects confi rmed that their use of medications was unchanged. Those reporting noncompliance or change in medication were rescheduled. Subjects provided separate written informed consent for the laboratory session before any study procedures.
Recent abstinence from alcohol consumption was confi rmed using standard instruments (Intoxylizer 400PA; CMI, Inc., Owensboro, KY). Initial breath alcohol concentrations (BrACs) were required to be .000 g/dl. Subjects were required to produce a negative urine drug screen (i.e., benzodiazepines, amphetamines, cocaine, marijuana, and opiates) and pregnancy test (women of childbearing potential only). Subjects consumed a light snack (~220 calories) approximately 1 hour before alcohol administration.
Alcohol administration
The quantity of medical-grade alcohol (100% ethanol) necessary to achieve assigned BrACs was calculated using sex-defi ned modifi cations of the Widmark formula (Watson et al., 1981) . Alcohol was mixed with 366 ml of vehicle (ice-cold, sugar-free lemon-lime soda) and administered according to standard procedures (Fillmore et al., 2000) . Placebo beverages contained only vehicle. Drinks and serving trays were misted with alcohol to enhance placebo effectiveness. Beverages were split into two servings consumed by the participant within 5 minutes. BrAC measurements were obtained 10, 25, 60, and 75 minutes after beverage administration. Twenty-fi ve minutes after alcohol administration, subjects consumed a "booster" beverage containing half their initial alcohol dose if their BrAC was less than or equal to half of target. Five subjects (two older) received an active booster. All other subjects received a placebo booster containing only vehicle. Subjective intoxication was assessed before and after each task using a 10-point Likert scale (1 = not at all, 10 = most in my life). Following testing (~2.5 hours), subjects were transported home when their BrAC was .01 g/dl.
Trail Making Test
The TMT (Reitan and Wolfson, 1993) , completed by subjects 10 minutes after alcohol consumption, has two parts. Part A is a simple psychomotor task requiring subjects to connect 24 numbered circles in sequence. Part B is more diffi cult, involving the connection of circles with alternating numbers and letters, engaging set-shifting and working memory processes. Time to complete both parts was recorded. The TMT typically required less than 5 minutes to complete.
Working memory task
The working memory task (Gazzaley et al., 2005) consisted of three trial blocks differing by instructional set and was completed 25 minutes after beverage administration and immediately following booster administration. Each of the 20 trials per block included two face and two scene "cue" stimuli presented in pseudo-random order to ensure that subjects could not anticipate their sequence. Cue stimuli were grayscale and presented for 800 ms each with a 200-ms interstimulus interval. After a 9-second delay, a probe image was presented. Subjects responded about whether the probe image was present in the preceding set (50% probability/ trial). Subjects completed trial blocks with all three instruction sets in a counterbalanced order. In one, subjects were instructed to remember faces and ignore scenes. In another, subjects remembered scenes and ignored faces. In a control condition, subjects viewed cue faces and scenes passively and then indicated the direction of an arrow replacing the probe image via button press. Accuracy and RT were collected for each trial. From these, the proportion of "hits" (correct responses to previously presented probes) and "correct rejections" (correct response to a previously absent [i.e., novel] probe) and their average RTs were derived. Effi ciency ratios (accuracy/RT), which were of primary interest, were then constructed for both trial types. Although reliability and validity measures are not available for behavioral outcomes from this task, some precedent for consistent performance across studies for this task has been established (Anguera and Gazzaley, 2012) . The task required approximately 25 minutes to complete.
Analysis strategy
SAS Version 9.3 (SAS Institute, Inc., Cary, NC) was used for all analyses. To characterize study groups, demographic variables shared by older and younger participants were subjected to 2 (age group) × 3 (alcohol dose) analysis of variance (ANOVA) (SAS PROC GLM; SAS Institute Inc., Cary, NC). Follow-up t tests were conducted to characterize detected interactions. One-way ANOVA (alcohol dose: placebo, .04 g/dl, .065 g/dl) was conducted to determine whether participants differed on age group-specifi c variables. Follow-up t tests were conducted to characterize detected dose effects. As a conservative test for betweengroup differences in descriptive variables, no corrections for type I error were applied. Potential confounding relationships between demographic variables and behavioral measures were examined using Pearson's r correlation matrices. Using this approach, six outcome variables (effi ciency, accuracy, and RT for hits and correct rejections) were correlated with each demographic and affective variable. Because of the large number of simultaneous tests, Bonferroni corrections were applied, resulting in a signifi cance threshold < .008 (i.e., 0.05 / 6 simultaneous tests per demographic/affective variable). No signifi cant correlations were detected.
Descriptive univariate statistics indicated that completion times for both parts of the TMT, but neither hit nor correct rejection effi ciency on the working memory task, were skewed and kurtosed. TMT completion times were logtransformed for analyses to correct the distribution (Tabachnick and Fidell, 1989) . Because of the relative simplicity of the "passive viewing" instruction set in the working memory task, almost all participants achieved 100% accuracy. In addition, RTs were signifi cantly faster in the passive viewing instruction set than in both the "remember face" and "remember scene" instructions (ps < .0001). Thus, data from the passive viewing instruction set were not included in behavioral analyses.
Hypotheses regarding Age × Alcohol interactions for TMT performance were tested using 2 (age group) × 3 (dose group) ANOVA. Preliminary analyses of working memory task data revealed a signifi cant three-way interaction of age group, dose, and trial type-repeated: hit vs. correct rejection, F(2, 84) = 5.83, p = .004. Thus, 2 (age group) × 3 (dose group) × 2 (repeated: instruction set [remember face vs. remember scene]) ANOVA was conducted separately for hits and correct rejections. Signifi cant or trend-level (i.e., p < .10) Age × Dose interactions were characterized by performing comparisons of dose effects (i.e., t tests) within each age group. Relevant between-group comparisons were pre-planned (i.e., dose effects within each age group). To minimize type I error, extraneous comparisons (e.g., age effects at each dose level) were excluded, and two-tailed t tests were used despite our directional hypotheses. Given the nature of hypotheses and planned comparisons, and to better characterize empirical questions, additional type I correction was not applied. Effect sizes (Cohen's d) are reported for signifi cant or trend-level comparisons to provide context for the results.
Results
Participants
Older (n = 39, 15 men) and younger (n = 51, 31 men) community-dwelling moderate drinkers were recruited for the study. Ninety-one percent were White, 4% were African American, and 4% reported another race or multiple races. Eleven percent were Hispanic. Means of demographic, affective, and alcohol-related variables by age group and dose assignment are presented in Table 1 .
Education level
There was no signifi cant main effect of age for years of education (p > .10), although a signifi cant Age Group × Dose interaction was detected, F(2, 84) = 5.37, p = .006. Follow-up analyses revealed that years of education were equivalent across dose groups for younger adults, but that older adults at the placebo and .04 g/dl dose levels had signifi cantly fewer years than those at the .065 g/dl level, t(23) = 2.72, p = .008, and t(25) = 2.91, p = .005, respectively. All other effects were nonsignifi cant (Fs < 1).
Affective measures
State anxiety was higher in older than younger participants, F(1, 83) = 4.80, p = .03, but levels were not indicative of signifi cant distress. No main effect of dose or Age × Dose Group interaction was detected (ps > .8).
Among older adults, a trend-level effect of the dose group was detected for GDS scores (p = .09), with those given placebo having greater depressive symptomatology than those at the .04 g/dl dose level, t(23) = 2.54, p = .02. The (a) .04 g/ dl and .065 g/dl groups and (b) placebo and .065 g/dl did not differ signifi cantly (ps > .12). No differences were detected between dose groups for BDI-II scores in younger adults (p (n = 15) (n = 17) (n = 12) (n = 13) (n = 14) > .43). Depressive symptomatology was within normal limits for all participants.
Alcohol consumption
A trend-level Age Group × Dose interaction was noted for QFI (average ounces of absolute ethanol consumed per day), F(2, 84) = 2.86, p = .06. Follow-up analyses indicated that among older participants, those in the placebo group had higher average daily alcohol consumption than the .04 g/dl dose group, t(25) = 2.27, p = .03. The placebo group also had a higher mean QFI than the .065 g/dl dose group, although this difference was nonsignifi cant, t(24) = 1.75, p = .08. No differences in QFI were detected between dose groups in younger adults.
Breath alcohol concentration measures and subjective intoxication
BrACs achieved in each age group and active dose condition are shown in Figure 1 . As expected, a 2 (age group) × 2 (active dose level: .04 g/dl and .065 g/dl) ANOVA revealed signifi cant differences between BrACs resulting from the two active dose levels at each time point, F(1, 53) > 21, ps < .0001. No differences in BrAC between older and younger participants were noted at any point in either active dose group (all ps > .40). In addition, although expected dose effects were detected for subjective intoxication measures (ps < .0001), no signifi cant age effects or Age × Alcohol Dose interactions were noted (ps > .30).
Trail Making Test
The 2 (age group) × 3 (dose) ANOVA revealed the main effects of age group and dose, F(1, 89) = 31.64, p < .0001, and F(2, 89) = 3.13, p = .05 (Figure 2) , respectively, for completion time on Part A of the TMT but no interaction (p > .78). Older adults exhibited slower completion times than younger adults, M older = 31.09 (8.50s) versus M younger = 22.57 (6.75s); Cohen's d = 1.11. Follow-up t tests for the dose main effect revealed that the .04 g/dl dose level, M .04 = 24.06 (6.32s), was associated with faster completion times FIGURE 1. Breath alcohol concentration (BrAC) measures taken across the study session, by age group and dose. Signifi cant effects of dose level, F(1, 53) > 21, p < .0001, but not age group were detected at each time point (ps > .40). As expected, a paired-samples t test indicated that mean BrACs were higher at working memory task administration than Trail Making Test (TMT) administration, t(58) = 4.90, p < .001. WM = working memory; mins = minutes. 
Working memory task hit effi ciency
The 2 (age group) × 3 (dose) × 2 (repeated: instruction set) ANOVA for hit effi ciency detected signifi cant main effects of age group, F(1, 84) = 29.83, p < .0001, and instruction set, F(1, 84) = 18.41, p < .0001, as well as a trend-level Age Group × Dose interaction, F(2, 84) = 2.53, p = .09. As expected, younger subjects were signifi cantly more effi cient than older subjects, M younger = 0.73 (0.25) versus M older = 0.52 (0.20); Cohen's d = 0.92. Hit effi ciency in the "remember face" instruction, M face = 0.70 (0.26), was signifi cantly higher than in the "remember scene" instruction, M scene = 0.58 (0.21); Cohen's d = 0.51. Planned comparisons following the trendlevel Age Group × Dose interaction revealed no signifi cant dose effects on hit effi ciency for younger subjects (p > .32). In contrast, hit effi ciency for older adults at the .04 g/dl dose level was higher than at placebo, t(23) = 2.34, p = .03; Cohen's d = 0.91. Placebo versus .065 g/dl and .04 g/dl versus .065 g/ dl comparisons were not signifi cant (ps > .14). These effects and their characterization are illustrated in Figure 2 .
Working memory task hit accuracy
Characterization of alcohol dose and age group effects on hit accuracy using similarly constructed ANOVA revealed the main effects of age group, F(1, 84) = 9.58, p = .003, and instruction set, F(1, 84) = 11.62, p = .001, and a trend-level Age Group × Dose interaction, F(2, 84) = 2.78, p = .07. Hit accuracy was, on average, higher for younger subjects than for their older counterparts, M younger = 84.4 (12.8%) versus M older = 75.2 (16.0%); Cohen's d = 0.63. Likewise, hit accuracy was higher in the remember face than remember scene instruction set, M face = 84.8 (17.9%) versus M scene = 76.3 (19.0%); Cohen's d = 0.46. Characterization of the Age Group × Dose interaction revealed that increasing dose was associated with nonsignifi cant reductions in hit accuracy relative to placebo for younger subjects (ps > .10). However, older adults showed a dose effect on hit accuracy that mirrored dose effects on hit effi ciency. Hit accuracy was higher for older adults at the .04 g/dl dose level than either the placebo, t(23) = 2.03, p = .05; Cohen's d = 0.81, or .065 g/ dl dose level, although at a trend level, t(25) = 1.95, p = .07; Cohen's d = 0.75. The placebo and .065 g/dl dose levels did not differ from one another (p > .75).
Working memory task hit reaction time
Analysis of age group, dose group, and instruction set effects on hit RT revealed predicted age-related slowing, F(1, 84) = 23.84, p < .0001; M younger = 1,236.60 ms (279.2) FIGURE 2. Analysis of dose effects by age group on hit performance. (A) Trend-level interaction of age group and dose on hit effi ciency, F(2, 84) = 2.53, p = .09. Older subjects (Ss) were more effi cient at .04 g/dl than placebo, t(23) = 2.34, p = .03. No dose effects on hit effi ciency were detected for younger subjects. (B) Older subjects at .04 g/dl had higher hit rates than those at placebo, t(23) = 2.03, p = .05, or .065 g/dl, although at a trend level, t(25) = 1.95, p = .07. No dose effects on hit accuracy were noted for younger subjects (ps > .11). (C) No alcohol dose effects on hit reaction time (RT) were detected for either age group (ps > .11).
than placebo, M placebo = 28.58 (7.92s); t (60) 
Working memory task correct rejection effi ciency
The 2 (age group) × 3 (dose) × 2 (repeated: instruction set) ANOVA for working memory task correct rejection effi ciency revealed an expected main effect of age, F(1, 84) = 16.30, p = .0001, with older adults having lower effi ciency than younger adults, M older = 0.66 (0.18) versus M younger = 0.83 (0.19); Cohen's d = 0.92, and an Age Group × Dose interaction, F(2, 84) = 4.04, p = .02. Characterization of the Age Group × Dose interaction showed that younger adults at the .065 g/dl dose level were more effi cient than those at placebo, albeit at a trend level, t(34) = 1.81, p = .07; Cohen's d = 0.56; the .04 g/dl dose level was not signifi cantly different from either dose (ps > .26). In contrast, older adults at the .065 g/dl dose level were signifi cantly less effi cient than those at placebo, t(24) = 2.06, p = .04; Cohen's d = 0.79. Again, the .04 g/dl dose level was not signifi cantly different from either of the others (ps > .24). These interactive effects and their subsequent characterization are illustrated in Figure 3 .
Finally, an Age Group × Dose × Instruction Set interaction, F(2, 84) = 3.04, p = .05, was also noted. Age Group × Dose interactions were in turn detected for both the remember face and the remember scene instruction sets, F(2, 84) = 3.71, p = .03, and F(2, 84) = 3.95, p = .02, respectively. Simple main effects analysis for the remember face instruction revealed that older adults at the .065 g/dl dose level had poorer effi ciency than those at placebo, t(24) = 2.04, p = .04; Cohen's d = 0.90, or the .04 g/dl dose level, t(25) = 1.87, p = .06; Cohen's d = 0.87, although the latter comparison was trend level. The .04 g/dl and placebo dose levels did not differ (p > .84). Dose had no effect on the effi ciency of younger subjects in this instruction set (ps > .19).
For the remember scene instruction, simple main effects analysis showed that younger adults at the .065 g/dl dose level had better effi ciency than those at placebo, t(34) = 2.20, p = .03; Cohen's d = 0.79. However, no differences between the .04 g/dl and either other dose level were detected (ps > .13). No signifi cant dose effects were found on correct rejection effi ciency for older adults (ps > .10).
Working memory task correct rejection accuracy
Main effects of age group and dose were identifi ed for correct rejection accuracy, F(1, 84) = 6.01, p = .02, and F(2, 84) = 7.57, p = .001, respectively. Older subjects had a lower correct rejection accuracy, M older = 90.0 (9.2%), than younger subjects, M younger = 93.8 (5.4%); Cohen's d = 0.50, FIGURE 3. Analysis of age group by dose effects on correct rejection performance. (A) A signifi cant interaction of age group and dose on correct rejection effi ciency, F(2, 84) = 4.04, p = .02. Older subjects (Ss) at .065 g/ dl had signifi cantly lower effi ciency than placebo, t(24) = 2.06, p = .04; an opposite trend-level effect was noted for younger subjects, t(34) = 1.81, p = .07. (B) Signifi cant effect of dose on correct rejection accuracy across age groups, F(2, 84) = 7.57, p = .001. Subjects at the .065 g/dl dose level had lower accuracy than those at .04 g/dl, t(53) = 2.96, p = .02, or placebo, t(48) = 3.35, p = .001. (C) Trend-level Age Group × Dose interaction on correct rejection (CR) reaction time (RT), F(2, 84) = 2.78, p = .07. The .065 g/dl dose level was associated with decreased RT compared with placebo for younger subjects, t(34) = 1.72, p = .09). Older subjects showed a nonsignifi cant increase in RT (p > .12). and the .065 g/dl dose level, M .065 = 88.6 (9.1%), was associated with a lower accuracy for correct rejections than either the .04 g/dl dose, M .04 = 93.2 (6.1%); t(53) = 2.96, p = .02; Cohen's d = 0.59, or placebo, M placebo = 94.8 (5.2%); t(48) = 3.35, p = .001; Cohen's d = 0.84, across all subjects. No other main effects or interactions were noted (ps > .13).
Working memory task correct rejection reaction time
Both a main effect of age group and a trend-level Age Group × Dose interaction were noted for correct rejection RTs, F(1, 84) = 14.89, p = .0002, and F(2, 84) = 2.78, p = .07, respectively, with older subjects having a slower mean RT than younger subjects, M older = 1,441.00 (432.10 ms) versus M younger = 1,183.92 (267.4 ms); Cohen's d = 0.72. No other main effects or interactions were noted (ps > .11).
Interestingly, comparisons following the trend-level Age Group × Dose interaction revealed opposite patterns of increasing alcohol dose on RT for younger and older subjects. Trend-level speeding of correct rejection RT for younger subjects at the .065 g/dl dose level versus placebo was detected, t(34) = 1.72, p = .09; Cohen's d = 0.70. The .04 g/dl dose level was not signifi cantly different from either alternate dose (ps > .30). In contrast, nonsignifi cant slowing was seen for older adults at the .065 g/dl dose level (p > .12). The .04 g/dl was again not signifi cantly different from the other doses (ps > .23).
Discussion
Analyses indicated age-related defi cits in psychomotor, set shifting, and working memory performance consistent with the existing literature (Gazzaley et al., 2008; Verhaeghen et al., 2003) . The effects of acute alcohol administration were more variable. As predicted, simple psychomotor performance (i.e., TMT Part A) was not impaired by the moderate alcohol doses used in this study. However, a modest benefi t in simple psychomotor performance relative to placebo was noted at the lower dose for both age groups. We are unaware of previous reports describing such an effect in older adults. In contrast, there were medium to large impairments in TMT Part B performance in older adults at the higher dose level, a task previously shown to be sensitive to alcohol and age interactions (Gilbertson et al., 2009) .
Effects of age group and alcohol dose level on working memory effi ciency differed between trials with previously presented and previously unseen probes. For previously presented probes (hits), older adults at the lower dose had better effi ciency than those at the other dose levels, making their performance equivalent to that of younger adults. This increase in effi ciency was driven by an increase in accuracy. Although further work is needed, we speculate that this effect may be attributable to alcohol myopia; that is, the .04 g/ dl dose may have increased the focus of older adults on cue and/or probe stimuli, resulting in improved accuracy (Steele and Josephs, 1990) . If this is the case, then detected facilitatory effects of moderate alcohol administration on working memory performance in older adults may be attenuated in tasks where attention is divided. Alcohol administration had no effect on RT, suggesting that performance differences were not due to a speed/accuracy tradeoff.
An alternate explanation for the apparent facilitatory effect of the .04 g/dl dose level on effi ciency of responding to previously presented probes in older adults is related to the lower depressive symptomatology noted in the .04 g/dl group compared with the placebo or .065 g/dl dose levels. However, as noted in the Analysis strategy section, GDS score did not correlate signifi cantly with any dependent variable, including RT. Thus, differences in depressive symptomatology between dose groups in older adults do not appear to account for these results. However, future studies should consider potential confounding effects of subclinical depressive symptomatology on processing speed.
Age and alcohol effects on the effi ciency of responses to previously unseen probes (correct rejections) followed a divergent pattern. Younger adults performed more effi ciently at the highest dose level, similar to previous results (Sklar et al., 2012) . In contrast, older adults performed least effi ciently at the highest dose level. Despite negative effects of the .065 g/dl dose on accuracy of rejection across age groups, we found that this dose was associated with decreased RT for younger adults and increased RT for older adults. Decreased effi ciency in older adults appeared as a result of a combination of poorer accuracy and a nonsignificant increase in RT.
The processes underlying the differential effects of alcohol dose and age on hits and correct rejections are unclear. It is possible that these mechanisms relate to the effects of alcohol dose and age group on one or more aspects of working memory, including (a) the employed memory scanning strategies and/or (b) the costs (in terms of mental effort) associated with these strategies (Crowder, 1976; Donkin and Nosofsky, 2012; Sternberg, 1975) . However, we did not test these possibilities in the current study (see limitations below).
Study limitations
Observed differences in the effects of moderate alcohol administration on neuropsychological function in older adults may not be strictly attributable to age, per se. For example, although we minimized variability in blood glucose levels by requiring study participants to fast for at least 4 hours before the start of the laboratory session, it is possible that those participants whose sessions began relatively later (e.g., 10:30 A.M.) may have eaten breakfast outside the 4-hour window. Unfortunately, participants were not asked whether they had eaten before beginning their 4-hour fast. Therefore, although participants were aware that they would receive breakfast on arrival, potential variation in blood glucose levels because of this behavior cannot be assessed. Furthermore, although thorough screening was conducted to avoid inclusion of participants with potentially confounding medical histories, the effects of certain risk factors for neuropsychological decline-such as estrogen levels and sleep quality/quantity (Ratcliff and Van Dongen, 2009; Sherwin, 2012 )-on study measures cannot be assessed because these data were not collected. Educational attainment and occupational demands may also infl uence age-related changes in neuropsychological function. As previously noted, educational attainment did not correlate with effi ciency, accuracy, or RT measures in this study. Data related to occupational demand were not available for this analysis; however, future studies should include it as a consideration.
It is poorly understood whether physiological differences between sexes may modulate the effects of acute moderate alcohol on psychomotor, set shifting, and working memory performance. Thus, the potential interaction of sex with alcohol administration and age is of interest. However, insuffi cient numbers of older men at the placebo and .04 g/dl dose levels (n = 5 and n = 4, respectively) prevented meaningful analysis of sex effects and interactions. We are currently conducting studies designed to address this limitation.
In addition, the remember/ignore task used in this study was relatively straightforward, requiring maintenance of only two faces or scenes in working memory. Extending these results using a more diffi cult task, including additional cue stimuli, would help (a) determine whether detected Age Group × Alcohol Dose interactions differ as a function of memory load and (b) prevent ceiling effects on performance.
The between-subjects design of this study may be considered a limitation because within-subject designs minimize intersubject variability, maximizing power to detect treatment effects. Therefore, potentially important effects and interactions might have been detected with a within-subjects design. Although future studies would benefi t from repeated assessments, the between-subjects design of this study avoids issues related to practice effects or incomplete data that result from loss at follow-up.
Finally, although of signifi cant conceptual interest, a comprehensive signal detection analysis of remember/ignore task performance was not possible because participants did not indicate their level of confi dence when indicating whether stimuli were previously presented. Future studies would benefi t from inclusion of this measure.
Conclusions
Taken together, the results of this study suggest differential effects of moderate alcohol administration on working memory effi ciency in older and younger adults. Whether effects were negative or apparently benefi cial depended on age group, dose, and probe stimulus novelty. Of particular interest were fi ndings of improved effi ciency and accuracy for previously present stimuli under the .04 g/dl dose level in older adults. Analysis of electrophysiological data recorded during task performance, currently underway, may help elucidate potential attentional mechanisms underlying this study's fi ndings. In addition, further investigation using additional task modalities, including complex behavioral paradigms (e.g., simulated driving), is necessary. Such studies are ongoing in our laboratory.
